Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2019 03:00 ET | Source: H. Lundbeck A/S

Lundbeck appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer

Valby, Denmark, 8 March 2019 - H. Lundbeck A/S (Lundbeck) today announced the appointment of Keld Flintholm Jørgensen to the role of Chief Business Officer (CBO) heading Corporate Strategy &...
March 08, 2019 03:00 ET | Source: H. Lundbeck A/S

Lundbeck udnævner Keld Flintholm Jørgensen til koncerndirektør, Chief Business Officer

Valby, Danmark, 8. marts 2019 - H. Lundbeck A/S (Lundbeck) annoncerede i dag udnævnelsen af Keld Flintholm Jørgensen til Chief Business Officer (CBO). Keld skal stå i spidsen for Corporate Strategy...
February 28, 2019 03:15 ET | Source: H. Lundbeck A/S

Notice of Annual General Meeting

Valby, Denmark, 28 February 2019 – Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on: Tuesday 26 March 2019 at 10:00 am The general meeting will...
February 28, 2019 03:15 ET | Source: H. Lundbeck A/S

Indkaldelse til ordinær generalforsamling

Valby, Danmark, 28. februar 2019 – Der indkaldes herved til ordinær generalforsamling i H. Lundbeck A/S. tirsdag den 26. marts 2019 kl. 10:00 Generalforsamlingen afholdes på...
February 18, 2019 03:46 ET | Source: H. Lundbeck A/S

Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants

Valby, Denmark, 18 February 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 28,155 as a consequence of the exercise of employee warrants. ...
February 18, 2019 03:46 ET | Source: H. Lundbeck A/S

Kapitalforhøjelse i Lundbeck med 5.631 aktier (0,0028 % af udestående aktier) som følge af warrant-program for medarbejdere

Valby, Danmark, 18. februar 2019 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort beslutningen om at udvide aktiekapitalen med DKK 28.155 som følge af udnyttelsen af medarbejder-warrants. ...
February 14, 2019 09:00 ET | Source: H. Lundbeck A/S

Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder

The efficacy of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with bipolar I disorder was investigated in two three-week, double-blind,...
February 14, 2019 09:00 ET | Source: H. Lundbeck A/S

Lundbeck og Otsuka rapporterer om fase III-data for evaluering af brexpiprazol til behandling af maniske episoder associeret med bipolar lidelse type I

Effekten af brexpiprazol til behandling af akutte maniske episoder med og uden forskellige symptomer hos patienter med bipolar I blev undersøgt i to tre-ugers, dobbeltblindede,...
February 05, 2019 01:52 ET | Source: H. Lundbeck A/S

Annual Report 2018 for H.Lundbeck A/S

Annual Report 2018 for H.Lundbeck A/S Attachment ANNUALREPORT2018 ...
February 05, 2019 01:40 ET | Source: H. Lundbeck A/S

Lundbeck realized 8% growth in revenue (local currencies) and 48% growth in EPS in 2018

Financial report for the period 1 January to 31 December 2018 Lundbeck realized 8% growth in revenue (local currencies) and 48% growth in EPS in 2018 HIGHLIGHTS Revenue reached...